Brant Mittler

Gold-Standard Clinical Trials and Covid-19

Allysia Finley does a courageous public service by questioning the role of randomized controlled trials (RCTs) in understanding the right way to treat Covid or any other disease (“Medical Research’s Cross of ‘Gold’ Imperils Covid Treatments,” op-ed,…

Rebirth: My Best Failure Ever

In Today’s World, Is It Possible to Be an Idealist?

Left Has No Good Answers for U.S. Doctors

The Legacy of Eugenics Still Echoes in America

Doctors, Not Bureaucrats, Make Innovations

The Problems With Bundled Health Billing

Golden State’s Medi-Cal Is Not That Golden

Lock ’Em All Up in Prison, and Then What?

Big Brother, Big Insurance: Perfect Together

Macra: The Creature From the Black Lagoon?

Valve Jobs, Cost, Benefits and Medicare Rules

Finding the Medical Snowball in a Blizzard

Big Operation: Move Medical Power to People

High Deductibles in Health Insurance

Maybe We Should Talk About Sustainable Health Care

Letters: The Doctor Is On

The Doctor Is On: An Exchange To the Editor: Eric Topol’s vision of patients remotely transmitting diagnosis- and treatment-enabling data — discussed in Sandeep Jauhar’s review of “The Patient Will See You Now” (Feb. 15) — has long been a necessity…

Counterpoint: Too Young to Die

Accountability and Halting More Superbug Infections

Paths to Reliable Medical Justice

To the Editor: In “Learning From Litigation” (Op-Ed, May 17), Prof. Joanna C. Schwartz takes a useful development — that hospitals are starting to be more open about their mistakes — and leaps to the conclusion that there’s no reason to create a more…